During the past decade, Regional Clinical Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Clinical Hospital" #1 sponsor was "Celgene" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "AO GENERIUM" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Clinical Hospital" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Regional Clinical Hospital" are "Crohn Disease" (3 trials), "Lupus Nephritis" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "COVID-19" (1 trials) and "Cystic Fibrosis" (1 trials). Many other conditions were trialed in "Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Regional Clinical Hospital" are "Drug" (15 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "Dulaglutide" (2 trials), "Tirzepatide" (2 trials) and "Acetaminophen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Clinical Hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Regional Clinical Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Regional Clinical Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".